ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest drug trials news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks drug trials across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

Qureight raised $20 million in Series B funding led by Molten Ventures to build a general-purpose 3D AI model of the chest. The model cuts drug trial imaging decisions from two weeks to 48 hours. AstraZeneca and Bristol Myers Squibb already use the platform.
Summaries by ByteBrief